Your browser doesn't support javascript.
loading
Are the clinical guideline recommendations on gastroprotection being followed? A review in patients taking nonsteroidal anti-inflammatory drugs. / ¿Qué tanto se siguen las recomendaciones de las guías clínicas sobre gastroprotección? Una revisión en enfermos que consumen antiinflamatorios no esteroideos.
Velasco-Zamora, J A; Gómez-Reyes, E; Uscanga, L.
Afiliação
  • Velasco-Zamora JA; Residente de Gastroenterología, Instituto Nacional de Ciencias Médicas y Nutrición «Salvador Zubirán¼, Ciudad de México, México.
  • Gómez-Reyes E; Adscrita al Departamento de Gastroenterología, Instituto Nacional de Ciencias Médicas y Nutrición «Salvador Zubirán¼, Ciudad de México, México.
  • Uscanga L; Departamento de Gastroenterología, Instituto Nacional de Ciencias Médicas y Nutrición «Salvador Zubirán¼, Ciudad de México, México. Electronic address: luis.uscangad@gmail.com.
Rev Gastroenterol Mex ; 81(3): 121-5, 2016.
Article em En, Es | MEDLINE | ID: mdl-27316593
INTRODUCTION AND AIMS: The chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs) can cause complications in the gastrointestinal tract. The use of proton pump inhibitors (PPIs) is recommended in high-risk patients to prevent them. OBJECTIVE: The aim of this article was to evaluate the gastroprotection measures taken in persons with chronic NSAID use. MATERIALS AND METHODS: A descriptive cross-sectional study was conducted. The clinical records were reviewed of patients seen as outpatients at the Rheumatology Department over a 4-month period, choosing those with chronic NSAID use, and intentionally looking for gastroprotection measures according to the recommendations published by the American College of Gastroenterology. RESULTS: A total of 417 patients (347 women; mean age: 48.12±14.2 years) were included. The most frequent diagnosis was rheumatoid arthritis (65%). Nine patients (2.1%) had a history of peptic ulcer, 48 (11.5%) patients were 65 years of age or older, 26 (6.2%) patients took NSAIDs and aspirin, and 130 (31.2%) took NSAIDs with steroids. Tests for Helicobacter pylori infection were done in just 53 cases, and there were positive results in only 9 (16%). Some risk for gastrointestinal toxicity was established in 211 cases and only 65 (30.8%) received gastroprotection. In contrast, 31 (15%) patients received gastroprotection when there was no indication for it. CONCLUSION: Prophylaxis with PPIs in chronic NSAID users was inadequately employed. It was not prescribed in the majority of patients (69.2%) and it was used with no justification in others (15%).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gastropatias / Anti-Inflamatórios não Esteroides / Guias de Prática Clínica como Assunto / Inibidores da Bomba de Prótons Tipo de estudo: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Mexico Idioma: En / Es Revista: Rev Gastroenterol Mex Ano de publicação: 2016 Tipo de documento: Article País de publicação: México

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gastropatias / Anti-Inflamatórios não Esteroides / Guias de Prática Clínica como Assunto / Inibidores da Bomba de Prótons Tipo de estudo: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Mexico Idioma: En / Es Revista: Rev Gastroenterol Mex Ano de publicação: 2016 Tipo de documento: Article País de publicação: México